Ranibizumab Intraocular and Repaglinide and Metformin
Determining the interaction of Ranibizumab Intraocular and Repaglinide and Metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Metformin and repaglinide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Repaglinide and Metformin Tablets
- Ranibizumab Intraocular-Repaglinide Tablets
- Ranibizumab Intraocular-Repan
- Ranibizumab Intraocular-Repara Silver Nitrate Applicators
- Ranibizumab Intraocular-Replace
- Ranibizumab Intraocular-Replace Without Iron
- Repaglinide and Metformin-Ranibizumab ophthalmic
- Repaglinide and Metformin-Ranitidine
- Repaglinide and Metformin-Ranitidine Capsule
- Repaglinide and Metformin-Ranitidine Hydrochloride
- Repaglinide and Metformin-Ranitidine Injection
- Repaglinide and Metformin-Ranitidine Suspension